-
Vorapaxar (brand name Zontivity,
formerly known as SCH 530348) is a
thrombin receptor (protease-activated receptor, PAR-1)
antagonist based on the natural...
-
antagonists (which
inhibit the protease-activated
receptor 1 a.k.a. PAR-1)
Vorapaxar (Zontivity)
Thromboxane inhibitors Thromboxane receptor antagonists Terutroban...
-
Prasugrel B01AC23
Cilostazol B01AC24
Ticagrelor B01AC25
Cangrelor B01AC26
Vorapaxar B01AC27
Selexipag B01AC28
Limaprost B01AC30
Combinations B01AC56 Acetylsalicylic...
- (INN)
Vontrol Voquezna Dual Pak
Voquezna Triple Pak
Voquezna Voranigo vorapaxar (USAN, INN)
vorasidenib (INN)
Voraxaze voreloxin (USAN, INN) voriconazole...
-
receptor have been
developed for use as anti-clotting agents. SCH-79797
Vorapaxar, sold
under the
brand name Zontivity, is a first-in-class anti-platelet...
-
antibiotic actions which are not
shared with
other PAR1
antagonists such as
vorapaxar, so may be
mediated through a
different target than PAR1. Ahn HS, Foster...
-
development of a
muscarinic antagonist based on
himbacine failed but an analog,
vorapaxar, has been
approved by the FDA as a
thrombin receptor antagonist. Chackalamannil...
